Search Count: 9
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Identification Of Small-Molecule Binding Sites Of A Ubiquitin-Conjugating Enzyme-Ube2T Through Fragment-Based Screening
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2024-02-28 Classification: LIGASE Ligands: V23, EDO |
 |
Identification Of Small-Molecule Binding Sites Of A Ubiquitin-Conjugating Enzyme-Ube2T Through Fragment-Based Screening
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-02-28 Classification: LIGASE Ligands: V2R |
 |
Identification And Characterization Of Inhibitors Covalently Modifying Catalytic Cysteine Of Ube2T And Blocking Ubiquitin Transfer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2023-11-29 Classification: LIGASE/INHIBITOR Ligands: V6C, EDO |
 |
Identification And Characterization Of Inhibitors Covalently Modifying Catalytic Cysteine Of Ube2T And Blocking Ubiquitin Transfer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2023-11-29 Classification: LIGASE/INHIBITOR Ligands: V5L, EDO |